Cue Biopharma, Inc. (CUE)
31.40
-3.60
(-10.29%)
USD |
NASDAQ |
May 11, 16:00
31.40
0.00 (0.00%)
After-Hours: 17:02
Cue Biopharma Total Liabilities (Quarterly) : 16.71M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Moderna, Inc. | 4.08B |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Amgen, Inc. | 83.31B |
| Savara, Inc. | 50.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.14M |
| Shareholders Equity (Quarterly) | 26.43M |
| Debt to Equity Ratio | 0.1588 |
| Current Ratio | 2.741 |
| Net Debt Paydown Yield | 3.60% |